Yoshihiko Maehara
Molecular Biology · 2011–2019
A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 96 citations into it; #7,501 of 17,773 by trust here, #4,409 by citations
Whom Yoshihiko Maehara trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Ryuji Hamamoto (in Molecular Biology)
- Yusuke Nakamura (in Molecular Biology)
Who trusts Yoshihiko Maehara
- Ryuji Hamamoto (in Molecular Biology)
- Yusuke Nakamura (in Molecular Biology)
- N. Dohmae (in Molecular Biology)
- Takehiro Suzuki (in Molecular Biology)
- Makoto Nakakido (in Molecular Biology)
Papers from Yoshihiko Maehara's perspective
Ordered by how strongly the researchers Yoshihiko Maehara trusts endorse each paper. Same corpus, a different order for every researcher.
- Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins (Nature)
- SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
- Regulation of chromatin structure by site-specific histone H3 methyltransferases (Nature)
- Genome-wide map of nucleosome acetylation and methylation in yeast. (Cell)
- Caught up in a Wnt storm: Wnt signaling in cancer. (Biochimica et Biophysica Acta)
- The language of covalent histone modifications (Nature)
- Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. (New England Journal of Medicine)
- Regulation of Alternative Splicing by Histone Modifications (Science)
- Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
- Maintaining genome stability at the replication fork (Nature reviews. Molecular cell biology)
Their papers
- Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers (2011) — 318 citations
- Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer (2011) — 114 citations
- Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B (2012) — 120 citations
- Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. (2011) — 100 citations
- The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6 (2011) — 68 citations
- The histone methyltransferase Wolf–Hirschhorn syndrome candidate 1‐like 1 (WHSC1L1) is involved in human carcinogenesis (2013) — 67 citations
- A Positive Correlation Between the EZH2 and PD-L1 Expression in Resected Lung Adenocarcinomas. (2019) — 34 citations
- Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer (2018) — 12 citations
- The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene (2012) — 96 citations